THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
发明人:
FU, YANG-XIN,CAO, XUEZHI
申请号：
CA3067539
公开号：
CA3067539A1
申请日:
2018.06.18
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present disclosure is directed to interferon prodrugs and their use in treating cancer. A particular advantage to such constructs is their ability to exert powerful anti-tumor activity in vivo reduction in many of the significant toxicities associated with interferon therapy.
